Aideen E Ryan

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

International journal of molecular sciences

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Niamh A Leonard, Eileen Reidy, Kerry Thompson, Emma McDermott, Eleonora Peerani, Elena Tomás-Bort, Frances R Balkwill, Daniela Loessner, Aideen E Ryan
Stromal Cells Promote Matrix Deposition, Remodelling and an Immunosuppressive Tumour Microenvironment in a 3D Model of Colon Cancer. Cancers 13 (23) (2021)
Christopher L McGinity, Erika M Palmieri, Veena Somasundaram, Dibyangana D Bhattacharyya, Lisa A Ridnour, Robert Y S Cheng, Aideen E Ryan, Sharon A Glynn, Douglas D Thomas, Katrina M Miranda, Stephen K Anderson, Stephen J Lockett, Daniel W McVicar, David A Wink
Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment. International journal of molecular sciences 22 (13) (2021)
Eileen Reidy, Niamh A Leonard, Oliver Treacy, Aideen E Ryan
A 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance. Cancers 13 (2) (2021)
Andrea Lees, Alexander J McIntyre, Nyree T Crawford, Fiammetta Falcone, Christopher McCann, Caitriona Holohan, Gerard P Quinn, Jamie Z Roberts, Tamas Sessler, Peter F Gallagher, Gemma M A Gregg, Katherine McAllister, Kirsty M McLaughlin, Wendy L Allen, Laurence J Egan, Aideen E Ryan, Melissa J Labonte-Wilson, Philip David Dunne, Mark Wappett, Vicky M Coyle, Patrick G Johnston, Emma M Kerr, Daniel B Longley, Simon S McDade
The pseudo-caspase FLIP(L) regulates cell fate following p53 activation. Proceedings of the National Academy of Sciences of the United States of America 117 (30) (2020)
Grace O'Malley, Oliver Treacy, Kevin Lynch, Serika D Naicker, Niamh A Leonard, Paul Lohan, Philip D Dunne, Thomas Ritter, Laurence J Egan, Aideen E Ryan
Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer. Cancer immunology research 6 (11) (2018)